Adamas Pharma secures approval for Parkinson's dyskinesia drug

(Reuters) - The U.S. Food and Drug Administration (FDA) said it had approved Adamas Pharmaceuticals Inc's treatment for a side effect caused by a commonly prescribed Parkinson's drug, sending the shares of the drugmaker soaring in after-market trading.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news